Publications by authors named "Sridharan Jayamohan"

Claim this Profile
T
The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer.
Megharani Mahajan, Alondra L Rodriguez Sanchez, Sridharan Jayamohan, Dileep K Vijayan, Jessica D Johnson

Mol Cancer Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT5 inhibition sensitizes glioblastoma tumor models to temozolomide.
Shumpei Onishi, Sridharan Jayamohan, Ashis Chowdhury, Sarah Rivas, Yoshihiro Otani

Res Sq· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
Yihong Chen, Jessica D Johnson, Sridharan Jayamohan, Yi He, Prabhakar P Venkata

Mol Carcinog· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting S6K/NFκB/SQSTM1/Polθ signaling to suppress radiation resistance in prostate cancer.
Alison Clark, Michelle R Villarreal, Shih-Bo Huang, Sridharan Jayamohan, Paul Rivas

Cancer Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study.
Jessica D Johnson, Salvador Alejo, Sridharan Jayamohan, Gangadhara R Sareddy

Expert Opin Ther Targets· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.
Prabhakar Pitta Venkata, Sridharan Jayamohan, Yi He, Salvador Alejo, Jessica D Johnson

Cancer Lett· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.
Salvador Alejo, Bridgitte E Palacios, Prabhakar Pitta Venkata, Yi He, Wenjing Li, Sridharan Jayamohan

Neuro Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reticulocalbin 3 Is a Novel Mediator of Glioblastoma Progression.
Yi He, Salvador Alejo, Jessica D Johnson, Sridharan Jayamohan, Gangadhara R Sareddy

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of miRISC Regulatory Network Promotes Hepatocellular Carcinoma by Targeting PI3K/Akt Signaling Pathway.
Maheshkumar Kannan, Sridharan Jayamohan, Rajesh Kannan Moorthy, Siva Chander Chabattula, Mathan Ganeshan

Int J Mol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
Sridharan Jayamohan, Maheshkumar Kannan, Rajesh Kannan Moorthy, Nirmal Rajasekaran, Hun Soon Jung

Front Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for 2-Methoxyestradiol-Mediated Inhibition of Receptor Tyrosine Kinase RON in the Management of Prostate Cancer.
Izhar Singh Batth, Shih-Bo Huang, Michelle Villarreal, Jingjing Gong, Divya Chakravarthy, Sridharan Jayamohan

Int J Mol Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.
Maheshkumar Kannan, Sridharan Jayamohan, Rajesh Kannan Moorthy, Siva Chander Chabattula, Mathan Ganeshan

Int J Mol Sci· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
Sridharan Jayamohan, Maheshkumar Kannan, Rajesh Kannan Moorthy, Nirmal Rajasekaran, Hun Soon Jung

Front Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis